Patent · US Expired

Agents, which inhibit apoptosis in cells that are involved in wound healing

US7582725B2 · kind B2 · utility

2Cited by

3References

21Claims

0Family size

Assignee

Dermatools Biotech GmbH · DE

Inventors

Mark A. Freyberg · Darmstadt, DE
Peter Friedl · Groß-Umstadt, DE
Dirk Kaiser · Eppertshausen, DE

Key dates

Filing date	Feb 21, 2002
Grant date	Sep 1, 2009
Priority date	—
Expiry date	Apr 27, 2022

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2502/1323
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of substances as a fundamental constituent in wound healing agents. The invention is characterised in that said substances bond to either IAP and/or integrin αvβ3 and/or thrombuspondin-1 in such a way that the bond between thrumbospondin-1 and IAP and/or integrin αvβ3 is inhibited.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.